ELITE PHARMACEUTICALS INC /NV/ 4
4 · ELITE PHARMACEUTICALS INC /NV/ · Filed Jun 4, 2015
Insider Transaction Report
Form 4
Hakim Nasrat A
DirectorPresident & CEO
Transactions
- Conversion
Warrants
2015-06-02−1,982,106→ 0 total(indirect: By LLC)Exercise: $0.06From: 2011-03-31Exp: 2018-03-31→ Common Stock (1,982,106 underlying) - Conversion
Common Stock
2015-06-02$0.06/sh+2,741,801$171,363→ 5,311,819 total(indirect: By LLC) - Conversion
Warrants
2015-06-02−759,695→ 0 total(indirect: By LLC)Exercise: $0.06From: 2009-10-30Exp: 2016-10-30→ Common Stock (759,695 underlying)
Holdings
- 2,700,000(indirect: By IRA)
Common Stock
- 13,760,695
Common Stock